Back to search

Article

Liver endothelium promotes HER3-mediated cell survival in KRAS wild-type and mutant colorectal cancer cells

2021-07-26

Abstract excerpt

<title>Abstract</title> <p>We previously showed that human epidermal growth factor receptor 3 (HER3, also known as ERBB3) is a key mediator in liver endothelial cell (EC) promoting colorectal cancer (CRC) growth and chemoresistance, and suggested HER3-targeted therapy as a strategy for treating patients with metastatic CRC (mCRC) in the liver. Meanwhile, <italic>KRAS</italic> mutations occur in 40–50% of mCRC and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
391d9936-7361-56d2-b8ca-e333f8854dc0
DOI
10.21203/rs.3.rs-745208/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Liver endothelium promotes HER3-mediated cell survival in KRAS wild-type and mutant colorectal cancer cellsDOI 10.21203/rs.3.rs-745208/v1
Select a neighboring publication to make it the new centre.